The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Abiraterone + prednisone (Abi) +/- veliparib (Vel) for patients (pts) with metastatic castration-resistant prostate cancer (CRPC): NCI 9012 updated clinical and genomics data.
 
Maha Hussain
Consulting or Advisory Role - Abbvie; Bayer; Genentech/Roche
Research Funding - Genentech (Inst); PCCTC (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - TITLE: Dual Inhibition of MET and VEGF for the treatment of castration resistant prostate cancer and osteoblastic bone metastases. Applicant/Proprietor Exelexis, Inc. Application No/Patent No. 11764665.4- 1464 Application No/Pat; TITLE: METHOD OF TREATING CANCER Docket No: Serial Number: 224990/10-016P2/311733 61/481/671 Application Filed on: 5/2/2011; TITLE: SYSTEMS AND METHODS FOR TISSUE IMAGING, 3676 Our File: Serial Number: UM-14437/US-1/PRO 60/923,385 UM-14437/US-2/ORD 12/101,753
Travel, Accommodations, Expenses - Abbvie; Bayer; Genentech
 
Stephanie Daignault
Consulting or Advisory Role - Augmenix
Research Funding - Bayer (Inst); Pfizer (Inst)
 
Przemyslaw Twardowski
Stock and Other Ownership Interests - Exelixis
Honoraria - Astellas Medivation; Janssen
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - Astellas Medivation; Bayer; Janssen; Roche/Genentech; Sanofi
 
Costantine Albany
Honoraria - Sanofi
Consulting or Advisory Role - Seagen
Speakers' Bureau - Bayer; Sanofi
Research Funding - Astex Pharmaceuticals (Inst)
 
Mark N. Stein
Research Funding - Abbvie (Inst); Advaxis (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Oncoceutics (Inst)
 
Lakshmi Priya Kunju
No Relationships to Disclose
 
Dan R. Robinson
Patents, Royalties, Other Intellectual Property - University of Michigan; University of Michigan (Inst)
 
Kathleen A. Cooney
Patents, Royalties, Other Intellectual Property - patent pending on discovery of HOXB13 as prostate cancer susceptibility gene (Inst)
 
Robert B. Montgomery
Research Funding - ESSA; Ferring; Janssen Oncology; Medivation/Astellas
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Consulting or Advisory Role - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Daniel H. Shevrin
Consulting or Advisory Role - Astellas Oncology
Speakers' Bureau - Astellas Oncology; Bayer
 
Paul Gettys Corn
Speakers' Bureau - Sanofi
Research Funding - Exelixis (Inst); Sanofi (Inst)
 
Young E. Whang
Research Funding - Astellas Pharma (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Tokai Pharmaceuticals (Inst)
 
David C. Smith
Research Funding - Agensys (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); ESSA (Inst); Exelixis (Inst); Genentech (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Medivation/Astellas (Inst); Millennium (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Regeneron (Inst); Seagen (Inst); Takeda (Inst); Tekmira (Inst); Teva (Inst)
 
Megan Veresh Caram
No Relationships to Disclose
 
Scott A. Tomlins
Leadership - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
Consulting or Advisory Role - Abbvie; Astellas Medivation; Janssen; Roche; Sanofi; Strata Oncology; Ventana Medical Systems
Research Funding - Astellas Medivation (Inst); Compendia Bioscience (Inst); GenomeDx (Inst); Life Technologies (Inst); Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - I am a coauthor on a patent issued to the University of Michigan on ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe Inc., who has sublicensed some rights to Ventana Medical Systems/Roche.
Travel, Accommodations, Expenses - Compendia Bioscience; Life Technologies; Strata Oncology; Thermo Fisher Scientific
 
Karen E. Knudsen
Stock and Other Ownership Interests - Pfizer
Honoraria - Celgene; CellCentric
Consulting or Advisory Role - CellCentric
Research Funding - Celgene; Novartis; Sanofi
 
Walter Michael Stadler
Honoraria - AstraZeneca; Bayer; CVS Caremark; Johnson & Johnson; Merck; Sotio
Consulting or Advisory Role - AstraZeneca; Bayer; CVS Caremark; Johnson & Johnson; Merck; Sotio
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Johnson & Johnson (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst)
Other Relationship - American Cancer Society; UpToDate
 
Felix Yi-Chung Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; GenomeDx; Medivation/Astellas
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Arul M. Chinnaiyan
Employment - Consultant; Tempus
Consulting or Advisory Role - Armune Bioscience; Esanik; OncoFusion Therapeutics; Tempus
Patents, Royalties, Other Intellectual Property - GenomeDx; Hologic